Priorities for clinical research in intracerebral hemorrhage - Report from a National Institute of Neurological Disorders and Stroke Workshop

被引:103
作者
Morgenstern, LB
Woodbury-Harris, K
Marler, JR
机构
[1] Univ Michigan, Stroke Program, Ann Arbor, MI 48109 USA
[2] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[3] NINDS, Rockville, MD USA
[4] Washington Univ, St Louis, MO USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Northwestern Univ, Chicago, IL 60611 USA
[7] Scripps Res Inst, La Jolla, CA USA
[8] Univ Texas, Houston, TX USA
[9] Univ Cincinnati, Cincinnati, OH 45221 USA
[10] Univ Med & Dent New Jersey, Newark, NJ 07103 USA
[11] Columbia Univ, New York, NY USA
[12] Massachusetts Gen Hosp, Boston, MA 02114 USA
[13] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[14] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[15] Univ Calif Los Angeles, Los Angeles, CA USA
[16] Johns Hopkins, Baltimore, MD USA
[17] Univ Chicago, Chicago, IL 60637 USA
关键词
acute care; brain edema; cerebral amyloid angiopathy; hematology; intracerebral hemorrhage; stroke; acute;
D O I
10.1161/01.STR.0000155685.77775.4c
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Spontaneous intracerebral hemorrhage (ICH) is one of the most lethal stroke types. In December 2003, a National Institute of Neurological Disorders and Stroke (NINDS) workshop was convened to develop a consensus for ICH research priorities. The focus was clinical research aimed at acute ICH in patients. Methods-Workshop participants were divided into 6 groups: ( 1) current state of ICH research; ( 2) basic science; and ( 3) imaging, ( 4) medical, ( 5) surgical, and ( 6) clinical methodology. Each group formulated research priorities before the workshop. At the workshop, these were discussed and refined. Results-Recent progress in management of hemorrhage growth, intraventricular hemorrhage, and limitations in the benefit of open craniotomy were noted. The workshop identified the importance of developing animal models to reflect human ICH, as well as the phenomena of rebleeding. More human ICH pathology is needed. Real-time, high-field magnets and 3-dimensional imaging, as well as high-resolution tissue probes, are ICH imaging priorities. Trials of acute blood pressure-lowering in ICH and coagulopathy reversal are medical priorities. The exact role of edema in human ICH pathology and its treatment requires intensive study. Trials of minimally invasive surgical techniques including mechanical and chemical surgical adjuncts are critically important. The methodologic challenges include establishing research networks and a multi-specialty approach. Waiver of consent issues and standardizing care in trials are important issues. Encouragement of young investigators from varied backgrounds to enter the ICH research field is critical. Conclusions-Increasing ICH research is crucial. A collaborative approach is likely to yield therapies for this devastating form of brain injury.
引用
收藏
页码:E23 / E41
页数:19
相关论文
共 228 条
[41]   Hydrocephalus: A previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage [J].
Diringer, MN ;
Edwards, DF ;
Zazulia, AR .
STROKE, 1998, 29 (07) :1352-1357
[42]   Admission to a neurologic/neurosurgical intensive cave unit is associated with reduced mortality rate after intracerebral hemorrhage [J].
Diringer, MN ;
Edwards, DF .
CRITICAL CARE MEDICINE, 2001, 29 (03) :635-640
[43]  
DONAUER E, 1992, INTRACEREBRAL HEMATO, P211
[44]  
DUNNE JW, 1987, Q J MED, V64, P739
[45]  
DURING MJ, 1993, LANCET, V341, P1607
[46]   Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats [J].
Ellsworth, JL ;
Garcia, R ;
Yu, J ;
Kindy, MS .
STROKE, 2003, 34 (06) :1507-1512
[47]  
ENZMANN DR, 1981, AM J NEURORADIOL, V2, P517
[48]   Effects of hypothermia on energy metabolism in mammalian central nervous system [J].
Erecinska, M ;
Thoresen, M ;
Silver, IA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (05) :513-530
[49]  
Feuerstein G, 1998, CELL MOL NEUROBIOL, V18, P695, DOI 10.1023/A:1020226020062
[50]   Plasminogen activators potentiate thrombin-induced brain injury [J].
Figueroa, BE ;
Keep, RF ;
Betz, AL ;
Hoff, JT .
STROKE, 1998, 29 (06) :1202-1207